MIA News Archives

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

Researchers interviewed people who were given medical advice to discontinue antidepressants.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.

Study reviews psychological interventions for antidepressant discontinuation.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

Study examines racial and ethnic disparities in the quality of care for Medicaid-enrolled children starting ADHD medication.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.